USPTO serial 79426610
Reviewed by CopyMark Law Group
Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific research and laboratory apparatus, and educational apparatus, in the nature of microfluidic diagnostic apparatus for research laboratory use for detecting cancer cells ; laboratory apparatus for detecting tumour cells in body fluids being microfluidic chip apparatus in the nature of electronic apparatus for electrophysiological measurement and testing of cells; laboratory equipment for detecting tumour cells in blood samples in the nature of research laboratory analyzers for testing and analyzing blood; medical laboratory research instrument for detecting tumour cells in biological samples for use in research; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; laboratory devices in the nature of medical laboratory research instruments for detecting tumour cells in biological samples; filters for blood and blood components for laboratory use; filters for blood and blood components for laboratory experiments; laboratory filters for detecting tumour cells in biological samples for use in research; laboratory filters for detecting tumour cells in blood samples for use in research. | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments in the nature of medical diagnostic apparatus for isolating and detecting circulating tumor cells, microfluidic apparatus in the nature of medical diagnostic apparatus for testing cancer cells, blood analysis apparatus for medical purposes, cell separation diagnostic apparatus for medical purposes for detecting cancer biomarkers in cells, medical apparatus for detecting cancer, diagnostic apparatus for analyzing biological fluids for medical purposes for detecting biomarkers in cancer cells, automated medical sample processing apparatus, namely sample preparation device for medical diagnostic uses, medical diagnostic apparatus for monitoring cancer progression through blood testing, veterinary diagnostic apparatus for detecting tumor cells in animals, medical apparatus for detecting cancer biomarkers in blood samples, medical testing apparatus testing for cancer for oncological diagnostics, and medical specimen collection instruments in the nature of a microfluidic-based system consisting of hard plastic slides for the collection of blood and medical specimen collection instruments in the nature of a microfluidic-based system consisting of glass slides and polydymethilsiloxane for the collection of blood, instruments in the nature of blood filters for isolating circulating tumor cells from blood samples, medical instruments for processing biological samples in the nature of apparatus for taking blood samples, and biopsy instruments; diagnostic, examination, and monitoring equipment in the nature of diagnostic apparatus for detecting cancer by detecting circulating tumor cells, medical diagnostic instruments for analyzing blood samples, medical monitoring apparatus for monitoring cancer progression through blood analysis in the nature of apparatus for blood analysis for monitoring cancer progression, medical monitoring instruments for detecting cancer by tracking circulating tumor cells, blood analysis equipment in the nature of apparatus for blood analysis for medical diagnostic purposes, cell analysis apparatus for medical use in the nature of Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cell-based testing; blood testing apparatus, namely, blood collecting tubes; apparatus for blood tests, namely, blood collecting tubes; automated analyzers for body fluids in the nature of apparatus for blood analysis; apparatus for tumour diagnosis in the nature of medical diagnostic apparatus for detecting cancer by detecting circulating tumor cells and microfluidic apparatus for medical diagnostic testing of cancer ; automatic analyzers for medical diagnosis in the nature of blood analysis apparatus; diagnostic apparatus for medical purposes in the nature of blood analysis apparatus; diagnostic apparatus for medical purposes in the nature of blood analysis diagnostic apparatus; apparatus for the diagnosis of oncological diseases in the nature of blood analysis diagnostic apparatus; blood testing instruments, namely, blood sampling tubes for medical diagnostic purposes; apparatus for carrying-out diagnostic tests for medical purposes in the nature of medical diagnostic apparatus for detecting cancer by detecting circulating tumour cells; diagnostic devices to detect tumour cells in body fluid samples in the nature of medical diagnostic apparatus for testing cancer cells; diagnostic devices to detect tumour cells in blood samples in the nature of medical diagnostic apparatus for testing cancer cells; immunochemical medical diagnostic devices for detecting and measuring tumour cells in blood samples in the nature of medical diagnostic apparatus for testing cancer cells; blood filters; apparatus for blood tests, namely, blood collecting tubes; blood testing equipment, namely, blood collecting tubes and microfluidic chips in the nature of blood testing apparatus; blood analysis apparatus, namely, blood collecting tubes and microfluidic chips in the nature of blood testing apparatus; filters for blood and blood components for medical purposes; apparatus for blood analysis, namely, blood collecting tubes and microfluidic chips in the nature of blood testing apparatus; filters for blood and blood components for medical use; blood filters for detecting tumour cells in biological samples; blood filters for detecting tumour cells in blood samples. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 1, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 1, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 1, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 1, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 11, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 11, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 25, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 27, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 26, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |